Michael Lepis, MD
Pain Medicine · Manasquan, NJNPI 1972686079
Payments from drug & device makers
Across 210 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$463
- Abbott$369
- Si-bone, Inc.$313
- Radius Health, Inc.$307
- Medtronic$306
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$266
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,907100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 32 | $463 |
| Abbott | 11 | $369 |
| Si-bone, Inc. | 13 | $313 |
| Radius Health, Inc. | 16 | $307 |
| Medtronic(2 entities) | 11 | $306 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 18 | $266 |
| Nevro Corp. | 10 | $224 |
| Biodelivery Sciences International, Inc. | 26 | $217 |
| Vertos Medical, Inc. | 4 | $179 |
| Alphatec Spine, Inc | 1 | $150 |
| Scilex Pharmaceuticals Inc. | 10 | $146 |
| Foundation Fusion Solutions, LLC | 10 | $140 |
| Fidia Pharma USA Inc. | 5 | $97 |
| Arbor Pharmaceuticals, Inc. | 6 | $93 |
| Zimmer Biomet | 3 | $91 |
| Daiichi Sankyo Inc. | 4 | $58 |
| Pacira Therapeutics, Inc. | 3 | $43 |
| Averitas Pharma Inc. | 2 | $42 |
| Bioventus LLC | 2 | $41 |
| Globus Medical | 2 | $41 |
| SPR Therapeutics, Inc | 2 | $32 |
| Valinor Pharma, LLC | 2 | $31 |
| Johnson & Johnson(2 entities) | 2 | $30 |
| Pfizer | 2 | $29 |
| Assertio Therapeutics, Inc. | 2 | $27 |
| Amgen | 2 | $27 |
| Redhill Biopharma Inc. | 2 | $26 |
| Painteq LLC | 1 | $22 |
| DJO, LLC | 1 | $20 |
| Avanos Medical | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| AstraZeneca | 1 | $14 |
| Vertex | 1 | $14 |
| Orthogenrx Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Invictus MIS$150
- iFuse Implant$136
- CD HORIZON SPINAL SYSTEM$133
- mild Device Kit$133
- Tymlos$103
How this compares
$3,907 in reported general payments places this provider in the 70th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 23 | $40,361 |
| RelistorMethylnaltrexone Bromide | 14 | $32,368 |
| BelbucaBuprenorphine Hcl | 17 | $13,065 |
| MovantikNaloxegol Oxalate | 32 | $13,058 |
| RoxicodoneOxycodone Hcl | 13 | $7,999 |
| Morphine Sulfate ErMorphine Sulfate | 100 | $7,189 |
| Xtampza ErOxycodone Myristate | 21 | $6,860 |
| NucyntaTapentadol Hcl | 13 | $4,333 |
| Gabapentin | 351 | $4,091 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 269 | $3,976 |
| Oxycodone Hcl | 117 | $3,284 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 227 | $2,778 |
| Metaxalone | 11 | $2,153 |
| Lidocaine | 20 | $2,122 |
| Methylprednisolone | 294 | $1,914 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia | $27 | $40,36123 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $266 | $32,36814 claims |
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta | $463 | $24,25851 claims |
| Redhill Biopharma Inc.Movantik | $26 | $13,05832 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 256 pain medicine providers in New Jersey.
Other pain medicine in Manasquan
- Sean LiShrewsbury$2.2M
- Matthias WiederholzLawrenceville$866K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$362K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Rajat SekharWhiting$84K
- Anson MoiseEnglewood$78K
- Samyadev DattaHackensack$65K
- Pavli DemianSomerset$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.